Prophylactic Neuroprotection

Author(s): Sean I. Savitz, Marc Fisher

Journal Name: Current Drug Targets

Volume 8 , Issue 7 , 2007

Become EABM
Become Reviewer


Ischemic brain injury can be anticipated in a number of clinical settings such as procedures associated with a high-risk for stroke, patients with transient ischemic attacks or minor strokes who are at substantial risk for early recurrence and patients with multiple vascular risk factors with an enhanced risk for ischemic stroke over many years. In such high-risk settings, it may be possible to employ neuroprotective drugs prophylactically to reduce the extent and clinical consequences of ischemic events. The concept of prophylactic neuroprotection can be envisioned for varying time periods and with a variety of drug classes depending upon the target population. This review will focus on which target populations should be considered for prophylactic neuroprotection trials and which drugs might be used in such trials.

Keywords: Neuroprotection, prophylactic, statins, infarct, stroke

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [846 - 849]
Pages: 4
DOI: 10.2174/138945007781077382
Price: $65

Article Metrics

PDF: 2